A share price of Marker Therapeutics Inc [MRKR] is currently trading at $1.39, up 2.96%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The MRKR shares have gain 8.59% over the last week, with a monthly amount glided 23.01%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Marker Therapeutics Inc [NASDAQ: MRKR] stock has seen the most recent analyst activity on March 05, 2025, when Canaccord Genuity initiated its Buy rating and assigned the stock a price target of $8. Previously, Piper Sandler started tracking the stock with Overweight rating on March 25, 2021, and set its price target to $6. On March 19, 2021, Cantor Fitzgerald initiated with an Overweight rating and assigned a price target of $6 on the stock. Piper Sandler downgraded its rating to a Neutral and decreased its price target to $2.50 on May 12, 2020. ROTH Capital initiated its recommendation with a Buy. In a note dated December 03, 2018, Piper Jaffray upgraded an Overweight rating on this stock.
Marker Therapeutics Inc experienced fluctuations in its stock price throughout the past year between $0.81 and $4.07. Marker Therapeutics Inc [NASDAQ: MRKR] shares were valued at $1.39 at the most recent close of the market.
Analyzing the MRKR fundamentals
Trailing Twelve Months sales for Marker Therapeutics Inc [NASDAQ:MRKR] were 4.69M which represents -35.99% decline. Gross Profit Margin for this corporation currently stands at -1.24% with Operating Profit Margin at -3.17%, Pretax Profit Margin comes in at -3.03%, and Net Profit Margin reading is -3.05%. To continue investigating profitability, this company’s Return on Assets is posted at -0.66, Equity is -0.92 and Total Capital is -0.81.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 1.3633 points at the first support level, and at 1.3367 for the second support level. However, for the 1st resistance point, the stock is sitting at 1.4133, and for the 2nd resistance point, it is at 1.4367.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Marker Therapeutics Inc [NASDAQ:MRKR] is 6.50. As well, the Quick Ratio is 6.50, while the Cash Ratio is 5.26. Considering the valuation of this stock, the price to sales ratio is 4.94, the price to book ratio is 1.26.
